ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$79.71
-0.19 (-0.24%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+13.61%
1Y
+399.44%
YTD
+17.58%
Open$80.71
Previous Close$79.90
Day High$82.84
Day Low$79.69
52W High$84.55
52W Low$14.30
Volume—
Avg Volume1.69M
Market Cap11.52B
P/E Ratio—
EPS$-2.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.84
Above
SMA 200
$36.65
Above
RSI (14)
36.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-12.8% upside
Current
$79.71
$79.71
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 873.47M | 580.30M | 3.64B |
| Net Income | -1,718,455 | -1,027,510 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 128.76M | 81.26M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |